Further elucidating the mechanism by which SDC1, and possibly other syndecans, regulates differentiation of MSCs could lead to new therapeutic targets in metabolic disorders such as obesity. This evidence concerns the gene SDC1 and obesity due to melanocortin 4 receptor deficiency.